Symbols

IART

Integra Lifesciences Holdings·NASDAQ

--(--)

5.22 / 10

Netural

Fund‑flow metrics are strong (7.88/10) with positive inflows across most investor sizes, though small‑cap flow is slightly negative. Analyst sentiment is bearish: one Strong Sell and one Neutral rating, weighted rating 2.57. The contrast creates a cautious stance despite solid capital inflows.

Fund Flow Rating

Analyst RatingStrong Sell

Wall Street Opinions

Strong Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

50%

Date2026-03-11

InstitutionCitigroup

Times predicted3

Historical Win Rate66.7%

What is the market sentiment for IART?

IART holds a Bearish analyst rating, with 50% of experts assigning a Strong Sell grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.22/10 (Netural).